Tuesday, May 11, 2021
Friday, May 7, 2021
BVX-0918A, the vaccine, uses the patient's own cancer cells to make them more recognizable to the body's defense system. Specifically, the vaccine would make the cancer cell more visible for cancer-killing T-cells. BioVaxys is also planning to combine their vaccine with checkpoint inhibitors, another class of cancer medication, that block certain proteins from shutting down the body's immune response. Cancer cells hijack this natural function in the body and therefore hide from the immune system.
To read more about this fascinating research, follow this link.
Tuesday, May 4, 2021
Tuesday, April 27, 2021
Because there are so many factors (genetic, environmental and acquired) that can cause cancerous mutations, trying to find patterns in the myriad interactions between cells is incredibly time consuming and unpredictable process. Some researchers will now have access to the powerful computing ability of AI to analyze large amounts of data. To find out more about this venture between OCRA and MS, follow this link.